Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04247503 · ClinicalTrials.gov registry record
Cohort Study of Pancreatic Cancer Risk
A clinical trial of Familial Pancreatic Cancer, sponsored by Mayo Clinic.
- Active
- Registry status
- 419
- Enrollment target
- 1
- Study location
NCT04247503: Active study of Familial Pancreatic Cancer, sponsored by Mayo Clinic.
NCT04247503 is a study of Familial Pancreatic Cancer that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 419 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04247503, a study of Familial Pancreatic Cancer, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 419 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to develop a cohort of individuals without pancreatic cancer, but who are at increased risk of developing it due to family history or genetic predisposition. These high-risk individuals will be asked to provide baseline and annual (serial) follow-up blood samples for the duration of the study funding. \[Blood collection was discontinued August 2025.\] Mayo Clinic is part of a national Pancreatic Cancer Detection Consortium (PCDC) which aims to establish a high-risk cohort with the goal of validating blood biomarkers (discovered/developed outside of this protocol) using the samples collected serially (annually) that predict or detect pancreatic cancer prior to clinical diagnosis.
Primary Outcome
Enumeration of number of new cases of pancreatic cancer and other cancers that incidentally develop from baseline enrollment among those who enroll in the cohort. This number will be a numerator for a risk ratio. The denominator will be person years at risk starting from age 50.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2019-12-11 |
| Est. Completion | 2027-12-31 |
What the registry record for NCT04247503 still lists
NCT04247503 is an observational study that tracks outcomes without assigning an intervention. The registered 419 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Familial Pancreatic Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04247503 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04247503 about?
NCT04247503 is a clinical study titled "Cohort Study of Pancreatic Cancer Risk". This study is designed to develop a cohort of individuals without pancreatic cancer, but who are at increased risk of developing it due to family history or genetic predisposition. These high-risk individuals will be asked to provide baseline and annual (serial) follow-up blood samples for the durat...
What is the current status of trial NCT04247503?
This trial is currently active not recruiting. The enrollment target is 419 participants. The study started on 2019-12-11. Estimated completion is 2027-12-31.
What conditions does trial NCT04247503 study?
This clinical trial studies the following conditions: Familial Pancreatic Cancer.
Who is sponsoring clinical trial NCT04247503?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04247503 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI